KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction

Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma

(2011) Z Qin et al.   LEUKEMIA

Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma

(2011) Bruno C. Jham et al.   PLoS One

Cancer incidence in the multicenter aids cohort study before and during the HAART era

(2010) Eric C. Seaberg et al.   CANCER

Receptor Activator of NF- B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147

(2010) N. Rucci et al.   CANCER RESEARCH

Direct Activation of Emmprin and Associated Pathogenesis by an Oncogenic Herpesvirus

(2010) Z. Qin et al.   CANCER RESEARCH

EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-κB andMKK7/JNK/AP-1 signaling

(2010) Balachandar Venkatesan et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV

(2010) Zhiqiang Qin et al.   VIROLOGY

EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2 -mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2

(2009) F. Bougatef et al.   BLOOD

Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy

(2009) S. Daouti et al.   CANCER RESEARCH

Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy

(2009) Hai-Yan Zhang et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

(2009) Alberto M Martelli et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

(2009) Sandra E. Ghayad et al.   INTERNATIONAL JOURNAL OF CANCER

Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response

(2008) Huong Q Nguyen et al.   AIDS

Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells

(2008) Zhouqing Huang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells

(2008) Xianling Guo et al.   BMC CANCER

Kaposi's Sarcoma-Associated Herpesvirus Confers a Survival Advantage to Endothelial Cells

(2008) L. Wang et al.   CANCER RESEARCH

Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells

(2008) M CIRONE et al.   IMMUNOLOGY LETTERS

Basigin-2 Is a Cell Surface Receptor for Soluble Basigin Ligand

(2008) Robert J. Belton et al.   JOURNAL OF BIOLOGICAL CHEMISTRY